Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 5
1986 1
1987 1
1988 1
1990 3
1991 5
1992 1
1993 5
1994 5
1995 3
1996 5
1997 5
1998 4
1999 2
2000 1
2001 2
2003 6
2004 3
2005 5
2006 8
2007 2
2008 5
2009 2
2010 2
2011 2
2012 3
2013 8
2014 5
2015 4
2016 8
2017 4
2018 7
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Results by year
Filters applied: . Clear all
Page 1
Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.
Hersh DS, Wadajkar AS, Roberts N, Perez JG, Connolly NP, Frenkel V, Winkles JA, Woodworth GF, Kim AJ. Hersh DS, et al. Among authors: Winkles JA. Curr Pharm Des. 2016;22(9):1177-1193. doi: 10.2174/1381612822666151221150733. Curr Pharm Des. 2016. PMID: 26685681 Free PMC article. Review.
EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.
Roos A, Dhruv HD, Peng S, Inge LJ, Tuncali S, Pineda M, Millard N, Mayo Z, Eschbacher JM, Loftus JC, Winkles JA, Tran NL. Roos A, et al. Among authors: Winkles JA. Mol Cancer Res. 2018 Jul;16(7):1185-1195. doi: 10.1158/1541-7786.MCR-18-0125. Epub 2018 May 3. Mol Cancer Res. 2018. PMID: 29724813 Free PMC article.
The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.
Hersh DS, Harder BG, Roos A, Peng S, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA. Hersh DS, et al. Among authors: Winkles JA. Neuro Oncol. 2018 Sep 3;20(10):1321-1330. doi: 10.1093/neuonc/noy063. Neuro Oncol. 2018. PMID: 29897522 Free PMC article.
Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.
Wadajkar AS, Dancy JG, Hersh DS, Anastasiadis P, Tran NL, Woodworth GF, Winkles JA, Kim AJ. Wadajkar AS, et al. Among authors: Winkles JA. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Jul;9(4):10.1002/wnan.1439. doi: 10.1002/wnan.1439. Epub 2016 Nov 4. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017. PMID: 27813323 Free PMC article. Review.
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.
Roberts NB, Wadajkar AS, Winkles JA, Davila E, Kim AJ, Woodworth GF. Roberts NB, et al. Among authors: Winkles JA. Oncoimmunology. 2016 Aug 19;5(9):e1208876. doi: 10.1080/2162402X.2016.1208876. eCollection 2016. Oncoimmunology. 2016. PMID: 27757301 Free PMC article. Review.
Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.
Connolly NP, Shetty AC, Stokum JA, Hoeschele I, Siegel MB, Miller CR, Kim AJ, Ho CY, Davila E, Simard JM, Devine SE, Rossmeisl JH, Holland EC, Winkles JA, Woodworth GF. Connolly NP, et al. Among authors: Winkles JA. Sci Rep. 2018 Jan 19;8(1):1180. doi: 10.1038/s41598-018-19451-6. Sci Rep. 2018. PMID: 29352201 Free PMC article.
Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.
Hersh DS, Peng S, Dancy JG, Galisteo R, Eschbacher JM, Castellani RJ, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA. Hersh DS, et al. Among authors: Winkles JA. J Neurooncol. 2018 Jun;138(2):241-250. doi: 10.1007/s11060-018-2799-3. Epub 2018 Feb 16. J Neurooncol. 2018. PMID: 29453678 Free PMC article.
116 results
Jump to page